← Back to Search

Behavioral Intervention

Telehealth for Opioid Use Disorder

N/A
Recruiting
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up substance use in past 7 days, measured at 14, 30, 90 days
Awards & highlights

Summary

This trial aims to create and test a new way of delivering treatment for Opioid Use Disorder (OUD) using telehealth. They want to find out what works best in this type of treatment

Who is the study for?
This trial is for individuals with opioid use disorder (OUD). It includes those currently in a 1-3 month buprenorphine treatment program and those approved for such treatment but not yet started. Participants must be willing to receive care via telehealth.
What is being tested?
The study is testing a tailored telehealth intervention designed to improve OUD treatment delivery, specifically using the medication buprenorphine. The trial will develop this intervention with stakeholder input and measure its effectiveness through clinical outcomes and patient satisfaction.
What are the potential side effects?
Since the focus of this trial is on the delivery method of OUD treatment rather than a new medication, side effects are primarily related to buprenorphine use which can include nausea, drowsiness, constipation, sweating, or potential dependency.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~substance use in past 7 days, measured at 14, 30, 90 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and substance use in past 7 days, measured at 14, 30, 90 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Treatment Engagement
Secondary study objectives
Acceptability
Days of medication for OUD
Feasibility of intervention
+3 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Patients with OUD, eligible for treatment with buprenorphineExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor
2,059 Previous Clinical Trials
43,129,820 Total Patients Enrolled
~40 spots leftby Apr 2028
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top